• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Trex Medical completes public offering

Article

X-ray vendor Trex Medical this month completed a public stockoffering that raised net proceeds of $49.8 million. Trex, of Danbury,CT, issued 2.9 million shares of stock at $14 a share, includingan over-allotment option of 375,000 shares. The stock was

X-ray vendor Trex Medical this month completed a public stockoffering that raised net proceeds of $49.8 million. Trex, of Danbury,CT, issued 2.9 million shares of stock at $14 a share, includingan over-allotment option of 375,000 shares. The stock was tradingat about $20 a share in mid-July. Parent company ThermoTrex retainsan 80% stake in Trex Medical.

In other Trex Medical news, the company announced that it hassigned a preferred provider deal to supply mammography and stereotacticbiopsy equipment to the Columbia/HCA hospital chain. Columbia/HCAhospitals will be able to purchase Lorad and Bennett mammographysystems and upright stereotactic biopsy devices, as well as Lorad'sprone stereotactic biopsy table.

The deal puts Trex in privileged company: Columbia/HCA hasa close equipment purchasing relationship with GE Medical Systemsas part of the multivendor service and asset management relationshipbetween the companies (SCAN 3/29/95).

Trex Medical CEO Hal Kirshner also reported that Trex has ambitiousplans for the upcoming Radiological Society of North America meetingin December. The company will use the Trex Medical logo at itsbooth for the first time, with subsidiary companies like Lorad,Bennett, XRE, and Continental occupying separate sections of theexhibit.

"We're going to have a very big booth," Kirshnersaid.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.